Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration - PubMed (original) (raw)
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration
C L Halbert et al. J Virol. 1997 Aug.
Abstract
The ability of recombinant adeno-associated virus (AAV) vectors to integrate into the host genome and to transduce nondividing cells makes them attractive as vehicles for gene delivery. In this study, we assessed the ability of several AAV vectors to transduce airway cells in rabbits by measuring marker gene expression. AAV vectors that transferred either a beta-galactosidase (beta-gal) or a human placental alkaline phosphatase (AP) gene were delivered to one lobe of the rabbit lung by use of a balloon catheter placed under fluoroscopic guidance. We observed vector-encoded beta-gal or AP staining almost exclusively in the epithelial and smooth muscle cells in the bronchus at the region of balloon placement. The overall efficiency of transduction in the balloon-treated bronchial epithelium was low but reached 20% in some areas. The majority of the staining was in ciliated cells but was also observed in basal cells and airway smooth muscle cells. We observed an 80-fold decrease in marker-positive epithelial cells during the 60-day period after vector infusion, whereas the number of marker-positive smooth muscle cells stayed constant. Although treatment with the topoisomerase inhibitor etoposide dramatically enhanced AAV transduction in primary airway epithelial cells in culture, treatment of rabbits did not improve transduction rates in the airway. Vector readministration failed to produce additional transduction events, which correlated with the appearance of neutralizing antibodies. These results indicate that both readministration and immune modulation will be required in the use of AAV vectors for gene therapy to the airway epithelium.
Similar articles
- Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.
Halbert CL, Standaert TA, Wilson CB, Miller AD. Halbert CL, et al. J Virol. 1998 Dec;72(12):9795-805. doi: 10.1128/JVI.72.12.9795-9805.1998. J Virol. 1998. PMID: 9811715 Free PMC article. - Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.
Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Halbert CL, et al. J Virol. 2000 Feb;74(3):1524-32. doi: 10.1128/jvi.74.3.1524-1532.2000. J Virol. 2000. PMID: 10627564 Free PMC article. - Repeated delivery of adeno-associated virus vectors to the rabbit airway.
Beck SE, Jones LA, Chesnut K, Walsh SM, Reynolds TC, Carter BJ, Askin FB, Flotte TR, Guggino WB. Beck SE, et al. J Virol. 1999 Nov;73(11):9446-55. doi: 10.1128/JVI.73.11.9446-9455.1999. J Virol. 1999. PMID: 10516053 Free PMC article. - Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
Lotfinia M, Abdollahpour-Alitappeh M, Hatami B, Zali MR, Karimipoor M. Lotfinia M, et al. Clin Exp Med. 2019 Aug;19(3):289-298. doi: 10.1007/s10238-019-00557-8. Epub 2019 May 3. Clin Exp Med. 2019. PMID: 31054018 Review. - Immune responses to adeno-associated virus vectors.
Zaiss AK, Muruve DA. Zaiss AK, et al. Curr Gene Ther. 2005 Jun;5(3):323-31. doi: 10.2174/1566523054065039. Curr Gene Ther. 2005. PMID: 15975009 Review.
Cited by
- Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.
Bennett J, Maguire AM, Cideciyan AV, Schnell M, Glover E, Anand V, Aleman TS, Chirmule N, Gupta AR, Huang Y, Gao GP, Nyberg WC, Tazelaar J, Hughes J, Wilson JM, Jacobson SG. Bennett J, et al. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9920-5. doi: 10.1073/pnas.96.17.9920. Proc Natl Acad Sci U S A. 1999. PMID: 10449795 Free PMC article. - Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.
Odom GL, Gregorevic P, Chamberlain JS. Odom GL, et al. Biochim Biophys Acta. 2007 Feb;1772(2):243-62. doi: 10.1016/j.bbadis.2006.09.007. Epub 2006 Sep 26. Biochim Biophys Acta. 2007. PMID: 17064882 Free PMC article. Review. - The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.
Lerch TF, Xie Q, Chapman MS. Lerch TF, et al. Virology. 2010 Jul 20;403(1):26-36. doi: 10.1016/j.virol.2010.03.027. Epub 2010 May 4. Virology. 2010. PMID: 20444480 Free PMC article. - Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.
Limberis MP, Wilson JM. Limberis MP, et al. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):12993-8. doi: 10.1073/pnas.0601433103. Epub 2006 Aug 22. Proc Natl Acad Sci U S A. 2006. PMID: 16938846 Free PMC article. - Adenovirus-associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus-associated virus vector-serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A.
Stanford S, Pink R, Creagh D, Clark A, Lowe G, Curry N, Pasi J, Perry D, Fong S, Hayes G, Chandrakumaran K, Rangarajan S. Stanford S, et al. Res Pract Thromb Haemost. 2019 Jan 25;3(2):261-267. doi: 10.1002/rth2.12177. eCollection 2019 Apr. Res Pract Thromb Haemost. 2019. PMID: 31011710 Free PMC article.
References
- Nature. 1994 Oct 27;371(6500):802-6 - PubMed
- Mol Cell Biol. 1990 Aug;10(8):4239-42 - PubMed
- Nat Genet. 1994 Oct;8(2):148-54 - PubMed
- J Virol. 1995 Mar;69(3):1473-9 - PubMed
- Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5719-23 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical